O
n May 30, President Trump promised that “some” of the big drug makers would announce “voluntary, massive drops in prices” in two weeks.
But not everyone in the pharmaceutical industry got the memo.
Unlock this article by subscribing to STAT Plus. Try it FREE for 30 days!
SUBSCRIBE TODAYWhat is it?
STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.
What's included?
- Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
- Subscriber-only networking events and panel discussions across the country
- Monthly subscriber-only live chats with our reporters and experts in the field
- Discounted tickets to industry events and early-bird access to industry reports
About the Author
And the patient is the one caught in the middle
Oh, so true! A co-worker just got a medication for her psoriasis, it came in the form of injections and it was 2 syringes, to the tune of 33,000! Thank goodness she has excellent insurance and paid 35.00.
Oddly, the Pfizer produced generic for Viagra is not mentioned – that might have a cost impact.